Abstract
Introduction

Heart failure is a leading cause of morbidity and mortality in industrialized countries (1). It is also a growing public health problem, mainly because of aging of the population and the increase in the prevalence of heart failure in the elderly. Previous basic, clinical, and population sciences have advanced the modern treatment of heart failure. Despite extensive studies, the fundamental mechanisms responsible for the development and progression of left ventricular (LV) failure have not yet been fully elucidated. Reactive oxygen species (ROS) such as superoxide anions (·O2 -) and hydroxy radicals (·OH) cause the oxidation of membrane phospholipids, proteins, and DNAs (2) and have been implicated in a wide range of pathological conditions including ischemia-reperfusion injury, neurodegenerative diseases, and aging. Under physiological conditions, their toxic effects can be prevented by such scavenging enzymes as superoxide dismutase (SOD), glutathione peroxidase (GSHPx), and catalase as well as by other non-enzymatic antioxidants.
However, when the production of ROS becomes excessive, oxidative stress might have a harmful effect on the functional and structural integrity of biological tissue. 
Recent experimental and clinical studies have suggested the generation of ROS to increase in heart failure (3-6). ROS cause contractile failure and structural damage in the myocardium. The importance of oxidative stress is increasingly emerging with respect to a pathophysiological mechanism of LV remodeling responsible for heart failure progression. By using electron spin resonance (ESR) spectroscopy combined with the nitroxide radical, 4-hydroxy-2,2,6,6-tetramethyl-piperidine-N-oxyl (hydroxy-TEMPO), a definitive and direct demonstration of enhanced generation of ROS was obtained in the failing myocardium (7)
.
